Brighton Jones LLC’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,450
| Closed | -$216K | – | 633 |
|
|
2023
Q4 | $216K | Buy |
+3,450
| New | +$216K | 0.01% | 519 |
|
|
2023
Q3 | – | Sell |
-3,800
| Closed | -$213K | – | 551 |
|
|
2023
Q2 | $213K | Buy |
+3,800
| New | +$213K | 0.01% | 495 |
|
|
2022
Q4 | – | Sell |
-3,830
| Closed | -$250K | – | 481 |
|
|
2022
Q3 | $250K | Sell |
3,830
-61
| -2% | -$3.98K | 0.01% | 368 |
|
|
2022
Q2 | $236K | Buy |
3,891
+104
| +3% | +$6.31K | 0.01% | 385 |
|
|
2022
Q1 | $238K | Buy |
3,787
+85
| +2% | +$5.34K | 0.01% | 432 |
|
|
2021
Q4 | $281K | Buy |
3,702
+777
| +27% | +$59K | 0.01% | 389 |
|
|
2021
Q3 | $327K | Buy |
2,925
+451
| +18% | +$50.4K | 0.02% | 347 |
|
|
2021
Q2 | $401K | Buy |
2,474
+7
| +0.3% | +$1.14K | 0.02% | 297 |
|
|
2021
Q1 | $301K | Sell |
2,467
-55
| -2% | -$6.71K | 0.02% | 311 |
|
|
2020
Q4 | $386K | Buy |
2,522
+16
| +0.6% | +$2.45K | 0.02% | 253 |
|
|
2020
Q3 | $210K | Buy |
+2,506
| New | +$210K | 0.01% | 307 |
|